semaglutide injection spring ridge Injections Rx Stock Up Now: Injectable Semaglutide

Stangherlin, A

This dual action produces multiple metabolic effects: Appetite suppression through central nervous system pathways affecting satiety centers Delayed gastric emptying , which prolongs feelings of fullness Enhanced insulin secretion in a glucose-dependent manner Reduced glucagon secretion , decreasing hepatic glucose production Weight loss-associated improvements in insulin sensitivity in peripheral tissues These effects occur systemically after subcutaneous absorption, with median peak concentrations reached in approximately 48-72 hours and a half-life of about 5 days allowing once-weekly dosing

The Overlap Risk: Why Concurrent Use Is Not Recommended The Pharmaceutical Journal (Royal Pharmaceutical Society, December 2025) states that concurrent administration of tirzepatide and semaglutide "could heighten side effects" due to their "overlapping incretin activity." When both drugs are active simultaneously, the GLP-1 receptor faces amplified agonist load

Tinsley et al

Patients with certain rs6923761 polymorphisms may experience more pronounced initial gastrointestinal effects, though this typically diminishes with dose titration

A person with lupus might be more likely to benefit from discussing a GLP-1 medicine with their clinician if they have: Type 2 diabetes Obesity or overweight with weight-related health problems High blood pressure High cholesterol Fatty liver disease High cardiovascular risk Kidney risk factors Difficulty losing weight despite serious lifestyle efforts These medicines may be especially worth discussing when weight, diabetes, or cardiovascular risk is making lupus care more difficult